Who We Are
Asia’s preferred healthcare distribution partner.
Everlife is Asia’s leading distribution partner for clinical diagnostics and laboratory sciences. We operate across a region full of opportunity, supporting principals to navigate diverse and resource intensive markets with our strong local knowledge and infrastructure.
Experts in healthcare and Asia, we combine our commitment to high ethical standards with a passionate and driven approach to impact what really matters. By enabling our customers and principals to do better, we add value to not only our business, but to the region as a whole.
Principal Highlights
We don’t just build business, we build trust.
Our goal is to be Asia’s partner of choice for medical devices and laboratory products. We are bringing this vision to life by partnering with the world’s most trusted brands and bringing them to Asia. Our partners trust us because we invest in long-term win-win relationships that can improve outcomes for all our stakeholders.
- Chemopharm Launches Revolutionary Novaerus Air Disinfection Devices in Malaysia
Kuala Lumpur, December, 2020 – Chemopharm Sdn Bhd, an Everlife company, has launched Novaerus air disinfection devices in Malaysia. Novaerus, […]
- Chemopharm wins 2020 ASEAN Business Award
Hanoi, November 13, 2020 – Chemopharm, an Everlife company, was awarded the ‘2020 ASEAN Business Award’ for their outstanding performance […]
- CPC Diagnostics launches first ICMR approved COVID-19 CLIA antibody test in India
Chennai, May 20, 2020 – CPC Diagnostics (‘CPC’), Chennai, a portfolio company of Everstone backed healthcare platform Everlife Holdings Pte. […]
- DV Medika marks launch of United Imaging in Indonesia with installation of uCT 760 at Stella Maris Hospital
October, 2019 – DV Medika, an Everlife investment and leading Indonesian distributor of medical devices, is proud to have installed […]
Contact Us
